SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

FibroGen Narrows Q1 Loss as Revenue Rises

05/10/2021 12:28

04:15 PM EDT, 05/10/2021 (MT Newswires) -- FibroGen (FGEN) on Monday narrowed its net loss to $0.78 per share in Q1 from $0.89 per share a year earlier as revenue jumped to $38.4 million from $24.4 million over the same period.

No analyst estimates were available for the drugmaker.

The company said the US Food and Drug Administration plans to tentatively hold an advisory committee meeting to review the company's new drug application for roxadustat on July 15.

Price: 19.10, Change: -0.32, Percent Change: -1.65